Look out, Lilly: Biogen's Aduhelm likely won't be the only Alzheimer's med subject to Medicare's coverage review
26th July 2021 Uncategorised 0 Look out, Lilly: Biogen’s Aduhelm likely won’t be the only Alzheimer’s med subject to Medicare’s coverage review
nhigginsdunn
Mon, 07/26/2021 – 11:17
More: Look out, Lilly: Biogen's Aduhelm likely won't be the only Alzheimer's med subject to Medicare's coverage review
Source: fierce